Loading clinical trials...
Loading clinical trials...
A Phase 1b study to evaluate the safety, tolerability and pharmacokinetics of multiple ascending doses of CNTX-6016 in healthy subjects and a single cohort to evaluate painful diabetic neuropathy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centrexion Therapeutics
NCT07195045 · Painful Diabetic Neuropathy (PDN), Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation), and more
NCT06524284 · Painful Diabetic Neuropathy
NCT05985291 · Painful Diabetic Neuropathy
NCT04055090 · Painful Diabetic Neuropathy, Diabetic Neuropathy, Painful
NCT03755934 · Painful Diabetic Neuropathy
AltaSciences
Overland Park, Kansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions